IL1B and Alzheimer disease: Alzheimer’s disease is associated with the aggregation of amyloid-β peptide (Aβ42/Aβ40) that develops into soluble neurotoxic oligomers, activating microglia and astrocytes to an acute inflammatory state that releases cytokines such as TNF-α, IL-1b, and IFN-γ.